Skip to main content

Asset Dedication, LLC

SEC CIK
0001475896
Latest filing
Jul 30, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Asset Dedication, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
237
Value
$117.7K
% of portfolio
<0.1%
Quarters held
14
Since Q1 2023
Holdings of VRTX by Asset Dedication, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026237$117.7K<0.1%00.0%UnchangedHolders
Q1 2026237$105.8K<0.1%−57−19.4%ReducedHolders
Q4 2025294$133.3K<0.1%00.0%UnchangedHolders
Q3 2025294$115.1K<0.1%+19+6.9%AddedHolders
Q2 2025275$122.4K<0.1%+71+34.8%AddedHolders
Q1 2025204$98.9K<0.1%−10−4.7%ReducedHolders
Q4 2024214$86.2K<0.1%+12+5.9%AddedHolders
Q3 2024202$93.9K<0.1%00.0%UnchangedHolders
Q2 2024202$94.7K<0.1%+100+98.0%AddedHolders
Q1 2024102$42.0K<0.1%00.0%UnchangedHolders
Q4 2023102$42.0K<0.1%00.0%UnchangedHolders
Q3 2023102$35.0K<0.1%+58+131.8%AddedHolders
Q2 202344$15.0K<0.1%00.0%UnchangedHolders
Q1 202344$14.0K<0.1%+44NewHolders